Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients

A. Borel-Derlon, A. B. Federici, V. Roussel-Robert, J. Goudemand, C. A. Lee, I. Scharrer, C. Rothschild, Erik Berntorp, C. Henriet, Z. Tellier, F. Bridey, P. M. Mannucci

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science